Gender bias in chronic lyme disease

Journal of Women's Health

Volumn 18, Issue 10, 2009, Pages 1717-1718

  Stricker, Raphael B ^a   Johnson, Lorraine ^a  

^a International Lyme and Associated Diseases Society   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BORRELIA BURGDORFERI; FEMALE; GENDER BIAS; HUMAN; IMMUNE RESPONSE; IMMUNOBLOTTING; LETTER; LYME DISEASE; NATURAL KILLER CELL; PRIORITY JOURNAL;

ADULT; ANTI-BACTERIAL AGENTS; CAUSALITY; CHRONIC DISEASE; COGNITION DISORDERS; COMORBIDITY; DEPRESSION; DIAGNOSIS, DIFFERENTIAL; FATIGUE SYNDROME, CHRONIC; FEMALE; FIBROMYALGIA; HUMANS; LYME DISEASE; MALE; SEX DISTRIBUTION; SEX FACTORS; SYNDROME;

EID: 70350451278     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2009.1657     Document Type: Letter

References (16)

1. Wormser GP, Shapiro ED. Implications of gender in chronic Lyme disease. J Womens Health 2009;18:831-834.
2. Centers for Disease Control and Prevention (CDC). Lyme disease-2008 case definition. Available at www.cdc.gov=ncphi=disss=nndss=casedef=lyme-disease- 2008.htm Accessed June 19, 2009.
3. Bacon RM, Kugeler KJ, Mead PS, Centers for Disease Control and Prevention (CDC). Surveillance for Lyme disease- United States, 1992-2006. MMWR Surveill Summary 2008; 57:1-9.
4. Feder HM Jr, Gerber MA, Luger SW, Ryan RW. Persistence of serum antibodies to Borrelia burgdorferi in patients treated for Lyme disease. Clin Infect Dis 1992;15:788-793.
5. Shepler LT. Sex bias in Lyme diagnosis. Posted on Avon website June 13, 2000. http:==www.centuryinter.net=tjs11= bug=15.htm. Accessed September 23, 2009.
6. Centers for Disease Control and Prevention (CDC). Lyme disease-United States, 2001-2002. MMWR 2004;53:365-369.
7. Stricker RB. Counterpoint: Long-term antibiotic therapy improves persistent symptoms associated with Lyme disease. Clin Infect Dis 2007;45:149-157.
8. Engstrom SM, Shoop E, Johnson RC. Immunoblot interpretation criteria for serodiagnosis of early Lyme disease. J Clin Microbiol 1995;33:419-427.
9. Ma B, Christen B, Leung D, Vigo-Pelfrey C. Serodiagnosis of Lyme borreliosis by Western immunoblot: Reactivity of various significant antibodies against Borrelia burgdorferi. J Clin Microbiol 1992;30:370-376.
10. Bennet L, Berglund J. Reinfection with Lyme borreliosis: a retrospective follow-up study in southern Sweden. Scand J Infect Dis 2002;34:183-186.
11. Jarefors S, Bennet L, You E, et al. Lyme borreliosis reinfection: might it be explained by a gender difference in immune response? Immunology 2006;118:224-232.
12. Bennet L, Stjernberg L, Berglund J. Effect of gender on clinical and epidemiologic features of Lyme borreliosis. Vector Borne Zoonotic Dis 2007;7:34-41.
13. Stricker RB, Winger EE. Decreased CD57 lymphocyte subset in patients with chronic Lyme disease. Immunol Lett 2001;76:43-48.
14. Shoemaker RC, Giclas PC, Crowder C, House D, Glovsky MM. Complement split products C3a and C4a are early markers of acute Lyme disease in tick bite patients in the United States. Int Arch Allergy Immunol 2008;146:255-261.
15. Stricker RB, Savely VR, Motanya NC, Giclas PC. Complement split products C3a and C4a in chronic Lyme disease. Scand J Immunol 2009;69:64-69.
16. Johnson L, Stricker RB. Attorney General forces Infectious Diseases Society of America to redo Lyme guidelines due to flawed development process. J Med Ethics 2009;35:283-288.